T-DM1 With or Without Abemaciclib for the Treatment of HER2-Positive Metastatic Breast Cancer
Stopped There are no patients enrolled on this study and all efforts are being discontinued
Conditions
- Anatomic Stage IV Breast Cancer AJCC v8
- HER2 Positive Breast Carcinoma
- Metastatic Breast Carcinoma
- Prognostic Stage IV Breast Cancer AJCC v8
Interventions
- DRUG: Abemaciclib
- BIOLOGICAL: Trastuzumab Emtansine
Sponsor
Academic and Community Cancer Research United
Collaborators